Navamedic ASA: Q3 2018 results
Oslo, 9 November 2018 – Navamedic ASA (OSE: NAVA) reported revenues of NOK 44.3 million in the third quarter of 2018, compared to NOK 44.9 million in the same period in 2017. The company significantly strengthened the gross margin to 34.9%, up from 27.8% in the same quarter last year, reflecting growth in higher margin products. The Pharma and Healthcare business area had a strong performance in the third quarter, with an EBITDA of NOK 3.5 million, and product launches are proceeding as planned.“As the results for the third quarter reflect, we are seeing positive effects from our continued